Search

Your search keyword '"Bouzas-Mosquera, Alberto"' showing total 609 results
Start Over Author "Bouzas-Mosquera, Alberto"
609 results on '"Bouzas-Mosquera, Alberto"'

1. Valor pronóstico de la razón desplazamiento sistólico del plano del anillo tricuspídeo/presión arterial pulmonar sistólica en la amiloidosis cardiaca

Author

Maccallini, Marta, Barge-Caballero, Gonzalo, Barge-Caballero, Eduardo, López-Pérez, Manuel, Bilbao-Quesada, Raquel, González-Babarro, Eva, Gómez-Otero, Inés, López-López, Andrea, Gutiérrez-Feijoo, Mario, Varela-Román, Alfonso, García-Seara, Javier, Bouzas-Mosquera, Alberto, and Crespo-Leiro, María G.

Published
2024
Full Text
View/download PDF

6. Evaluación económica de revascularización completa y revascularización guiada por ecocardiografía de estrés en el SCACEST con enfermedad multivaso

Author

Flores-Ríos, Xacobe, Calviño-Santos, Ramón A., Estévez-Loureiro, Rodrigo, Peteiro-Vázquez, Jesús, Salgado-Fernández, Jorge, Rodríguez-Vilela, Alejandro, Franco-Gutiérrez, Raúl, Bouzas-Mosquera, Alberto, Rodríguez-Fernández, José Ángel, Marzoa-Rivas, Raquel, González-Juanatey, Carlos, Aldama-López, Guillermo, Piñón-Esteban, Pablo, Vázquez-González, Nicolás, Muñiz-García, Javier, and Vázquez-Rodríguez, José Manuel

Published
2021
Full Text
View/download PDF

11. Impacto del tratamiento anticalcificación en la durabilidad de la bioprótesis Mitroflow y factores de riesgo para el deterioro valvular estructural

Author

Mosquera, Víctor X., Bouzas-Mosquera, Alberto, Velasco-García, Carlos, Vasquez-Echeverri, Daniel, Pradas-Irún, Concepción, González-Barbeito, Miguel, Estévez-Cid, Francisco, Bautista-Hernández, Víctor, Iglesias-Gil, Carmen, Fernández-Arias, Laura, García-Vieites, María, Portela-Torrón, Francisco, Herrera-Noreña, José María, and Cuenca-Castillo, José Joaquín

Published
2017
Full Text
View/download PDF

13. A cardiotoxicity dataset for breast cancer patients

Author

Piñeiro Lamas, Beatriz, López-Cheda, Ana, Cao, Ricardo, Ramos-Alonso, Laura, González-Barbeito, Gabriel, Barbeito Caamaño, Cayetana, Bouzas-Mosquera, Alberto, Piñeiro Lamas, Beatriz, López-Cheda, Ana, Cao, Ricardo, Ramos-Alonso, Laura, González-Barbeito, Gabriel, Barbeito Caamaño, Cayetana, and Bouzas-Mosquera, Alberto

Abstract

[Abstract] This dataset is a result of the collaboration between the University of A Coruña and the University Hospital of A Coruña. It contains information about 531 women diagnosed with HER2+ breast cancer, treated with potentially cardiotoxic oncologic therapies. These treatments can cause cardiovascular adverse events, including cardiac systolic dysfunction, the development of which has important clinical and prognostic implications. The availability of good predictors may enable early detection of these cardiac problems. Variables such as age, weight and height are available for each patient, as well as some measures obtained from echocardiography, a technique used prior and during the treatment to check the structure and function of the heart. Among them, there is a functional variable that measures the myocardial velocity during the cardiac cycle. For patients that experienced cancer therapy-related cardiac dysfunction during the treatment period, time until its appearance is known. This dataset aims to enable the scientific community in conducting new research on this cardiovascular side effect.

Published
2023

14. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography–Guided Revascularization in Patients With ST-Segment–Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

Author

Calviño-Santos, Ramón, Estévez-Loureiro, Rodrigo, Peteiro-Vázquez, Jesús, Salgado-Fernández, Jorge, Rodríguez-Vilela, Alejandro, Franco-Gutiérrez, Raúl, Bouzas-Mosquera, Alberto, Rodríguez-Fernández, José Ángel, Mesías-Prego, Alejandro, González-Juanatey, Carlos, Aldama-López, Guillermo, Piñón-Esteban, Pablo, Flores-Ríos, Xacobe, Soler-Martín, Rita, Seoane-Pillado, Teresa, Vázquez-González, Nicolás, Muñiz, Javier, and Vázquez-Rodríguez, José Manuel

Published
2019
Full Text
View/download PDF

19. Long-Term Prognostic Value of Mitral Regurgitation in Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

Author

López-Pérez, Manuel, Estévez-Loureiro, Rodrigo, López-Sainz, Ángela, Couto-Mallón, David, Soler-Martin, María Rita, Bouzas-Mosquera, Alberto, Peteiro, Jesús, Barge-Caballero, Gonzalo, Prada-Delgado, Oscar, Barge-Caballero, Eduardo, Salgado-Fernández, Jorge, Calviño-Santos, Ramón, Vázquez-Rodríguez, José Manuel, Piñón-Esteban, Pablo, Aldama-López, Guillermo, Vázquez-González, Nicolás, and Castro-Beiras, Alfonso

Published
2014
Full Text
View/download PDF

24. El «signo de la comba» como causa de insuficiencia mitral reversible durante la TAVI transapical

Author

Taboada Rodríguez, Uxía, Mosquera, Víctor X., Bouzas-Mosquera, Alberto, and Cuenca-Castillo, José Joaquín

Abstract

La insuficiencia mitral (IM) es una complicación que puede ocurrir durante el implante valvular aórtico transcatéter (TAVI) y puede requerir un tratamiento diferente dependiendo de su mecanismo. En este artículo, se describe el «signo de la comba» como causa de insuficiencia mitral severa debido al atrapamiento de la guía de alto soporte (Amplatz) en las cuerdas tendinosas del velo anterior mitral (VAM), causando el tetheringdel mismo contra la pared ventricular durante la realización de una TAVI transapical.

Published
2023
Full Text
View/download PDF

27. Additive prognostic and diagnostic value of diastolic exercise parameters in patients referred for exercise echocardiography.

Author

Peteiro, Jesús, Bouzas-Mosquera, Alberto, Barbeito-Caamaño, Cayetana, Martin-Alvarez, Esteban, Souto-Cainzos, Borja, and Vazquez-Rodriguez, Jose M

Subjects
EXERCISE tests, ECHOCARDIOGRAPHY, LEFT heart ventricle, MITRAL valve insufficiency, EXERCISE tolerance, CONFIDENCE intervals, MYOCARDIAL ischemia, MEDICAL protocols, COOLDOWN, DECISION making, HEART physiology, DIASTOLE (Cardiac cycle)
Abstract

Aims Exercise echocardiography (ExE) may evaluate left ventricular (LV) systolic and diastolic function. We aimed to assess the value of diastolic parameters at exercise [early LV inflow velocity to early tissue Doppler annulus velocity (E / e ′)] in patients with normal or abnormal resting diastolic function (DF) referred for a clinically indicated ExE. Methods and results LV systolic and DF according to ASE/EACVI guidelines and mitral regurgitation (MR) were evaluated at rest in 772 patients (age 67 ± 12 years) with preserved LV ejection fraction (LVEF ≥ 50%). We assessed regional/global LV systolic function at peak exercise, while MR and E / e ′ where evaluated in the immediate post-exercise period. Abnormal ExE was defined as ischaemia or fixed wall motion abnormalities, and raised E / e ′ values as >15 at rest and at exercise (e ′ at the septal level). Patients were grouped as complaining or not of dyspnoea. Events were overall mortality, myocardial infarction, admission for unstable angina or cardiac failure, and coronary revascularization. DF was abnormal at rest in 221 patients (29%) and indeterminate in 77 (10%), with similar percentages in patients with and without dyspnoea. Exercise E / e ′ >15 was found in 37% of patients with abnormal DF, 21% with indeterminate DF, and 6% with normal DF (P < 0.001). Patients with abnormal ExE had more often abnormal resting DF (39% vs. 25%, P = 0.001) and exercise E / e ′ >15 (25% vs. 13%, P < 0.001) than those with normal ExE. During a median follow-up of 1.68 years, there were 132 events. Independent predictors included peak exercise LVEF [hazard ratio (HR) = 0.93, 95% confidence interval (CI) = 0.91–0.94, P < 0.001], and exercise E / e ′ (HR= 1.04, 95% CI = 1.01–1.07, P = 0.01). Neither resting E / e ′ values nor resting abnormal DF by ASE/EACVI guidelines, were independent predictors. Annualized event-rates were 43.2% in patients with (+) ExE plus (+) exercise E / e ′, 23.8% in those with (+) ExE and (−) exercise E / e ′, 7.9% in (−) ExE and (+) exercise E / e ′, and 3.6% with both variables normal. Conclusions The results of diastolic dysfunction at rest and at exercise were similar between patients with or without dyspnoea referred for ExE, but they were associated with abnormal ExE. Exercise E / e ′ reclassified 21% of patients with indeterminate DF and further predicted outcome on top of ExE results. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

40. Light Chain and Transthyretin Cardiac Amyloidosis: Clinical Characteristics, Natural History and Prognostic Factors

Author

Barge-Caballero, Gonzalo, Vázquez-García, Raquel, Barge-Caballero, Eduardo, Couto-Mallón, David, Paniagua-Martín, María J., Barriales-Villa, Roberto, Piñón-Esteban, Pablo, Bouzas-Mosquera, Alberto, Pombo-Otero, Jorge, Debén-Ariznavarreta, Guillermo, Vázquez Rodríguez, José Manuel, Crespo-Leiro, María Generosa, Barge-Caballero, Gonzalo, Vázquez-García, Raquel, Barge-Caballero, Eduardo, Couto-Mallón, David, Paniagua-Martín, María J., Barriales-Villa, Roberto, Piñón-Esteban, Pablo, Bouzas-Mosquera, Alberto, Pombo-Otero, Jorge, Debén-Ariznavarreta, Guillermo, Vázquez Rodríguez, José Manuel, and Crespo-Leiro, María Generosa

Abstract

[Abstract] Introduction and objectives. Light-chain amyloidosis (AL-CA) and transthyretin amyloidosis (ATTR-CA) are the most common types of cardiac amyloidosis (CA). We sought to study the clinical characteristics and prognosis of both diseases. Methods. We conducted a single-centre, retrospective review of all patients diagnosed with CA between 1998 and 2018. Clinical characteristics, complementary tests, survival and other adverse clinical events were studied. Results. We identified 105 patients with CA, 65 ATTR-CA and 40 AL-CA. Mean age was 74.4 years; 24.8% were women. In both groups, heart failure was the most frequent clinical presentation (55.2%). The most prevalent electrocardiographic findings were the pseudoinfarct pattern (68.5%) and a Sokolow-Lyon index <1.5 mV (67.7%), with no differences between the two subtypes of CA. One-year, 3-year, and 5-year survival was 43.3%, 40.4% and 35.4%, respectively, in AC-AL patients, and 85.1%, 57.3% and 31.4% in AC-ATTR patients (p = .004). AL-CA subtype (HR 3.41, CI95% 1.45−8.06, p = .005), previous admission for heart failure (HR 4.25, 95% CI 1.63−11.09, p = .003) and a NYHA class III-IV (HR 2.76, 95% CI 1.09−7.03, p = .033) were independent predictors of mortality, while beta-blocker therapy was associated with longer survival (HR .23, 95% CI .09–.59, p = .002). Conclusions. Differences exist between the clinical presentation of AL-CA and ATTR-CA patients. Both diseases, particularly AL-CA, are associated with poor life prognosis., [Resumen] Antecedentes y objetivos. La amiloidosis cardiaca (AC) por cadenas ligeras (AC-AL) y por transtirretina (AC-ATTR) son los dos subtipos más frecuentes de la enfermedad. Nos propusimos caracterizar clínicamente estas entidades y analizar su pronóstico. Material y métodos. Realizamos una revisión retrospectiva de todos los pacientes diagnosticados de AC entre 1998 y 2018 en un centro español. Además de recoger las características clínicas y los resultados de las pruebas complementarias al diagnóstico, analizamos la supervivencia y la incidencia de desenlaces clínicos adversos. Resultados. Identificamos 105 pacientes con AC, 65 AC-ATTR y 40 AC-AL. La edad media era de 74,4 años; el 24,8% eran mujeres. En ambos grupos la insuficiencia cardiaca (IC) fue la forma de presentación clínica más frecuente (55,2%). Los hallazgos electrocardiográficos más prevalentes fueron el patrón de pseudoinfarto (68,5%) y un índice de Sokolow-Lyon <1,5 mV (67,7%), sin diferencias entre los dos subtipos. La supervivencia a 1, 3 y 5 años fue del 43,3%, 40,4% y 35,4%, respectivamente, en pacientes con AC-AL y de 85,1%, 57,3% y 31,4% en pacientes con AC-ATTR (p = 0,004). El subtipo AC-AL (HR 3,41, IC95% 1,45-8,06, p = 0,005), el ingreso previo por IC (HR 4,25, IC95% 1,63-11,09, p = 0,003) y una clase NYHA III-IV (HR 2,76, IC95% 1,09-7,03, p = 0,033) fueron predictores independientes de mortalidad, mientras que el tratamiento betabloqueante se asoció con una mayor supervivencia (HR 0,23, IC95% 0,09-0,59, p = 0,002). Conclusiones. Existen ciertas diferencias en la presentación clínica de los pacientes con AC-AL y AC-ATTR. Ambas entidades, y muy especialmente la AC-AL, presentan un pobre pronóstico vital.

Published
2021

42. Research update for articles published in EJCI in 2012

Author

Dullaart, Robin P.F., Al-Daghri, Nasser M., Ashina, Messoud, Bouzas-Mosquera, Alberto, Brunetti, Natale Daniele, Buechler, Christa, Chen, Harn-Shen, Corrales, Juan J., DʼArchivio, Massimo, Cas, Alessandra Dei, Pino, Guadalupe Garcia, Gómez-Abril, Segundo A., Györi, Dávid, Haslacher, Helmuth, Herder, Christian, Kerstens, Michiel N., Koutsilieris, Michael, Lombardi, Carlo, Lupattelli, Graziana, Mócsai, Attila, Msaouel, Pavlos, Orfao, Alberto, Ormazabal, Paulina, Pacher, Richard, Perkmann, Thomas, Peteiro, Jesús, Plischke, Max, Reynaert, Niki L., Ricci, Maria Anastasia, Robles, Nicolás Roberto, Rocha, Milagros, Rutten, Erica P.A., Sabico, Shaun, Santamaria, Francesca, Santoro, Francesco, Schmid, Andreas, Schmidt, Morten, Schytz, Henrik Winther, Shyu, Kou-Gi, Tada, Hayato, Thorand, Barbara, Valerio, Giuliana, Vesely, David L., Wu, Tzu-En, Yamagishi, Masakazu, and Yeh, Yao-Tsung

Published
2014
Full Text
View/download PDF

44. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

Author

Barge-Caballero, Gonzalo, primary, Vázquez-García, Raquel, additional, Barge-Caballero, Eduardo, additional, Couto-Mallón, David, additional, Paniagua-Martín, María J., additional, Barriales-Villa, Roberto, additional, Piñón-Esteban, Pablo, additional, Bouzas-Mosquera, Alberto, additional, Pombo-Otero, Jorge, additional, Debén-Ariznavarreta, Guillermo, additional, Vázquez-Rodríguez, José M., additional, and Crespo-Leiro, María G., additional

Published
2021
Full Text
View/download PDF

47. Amiloidosis cardíaca por cadenas ligeras y por transtirretina: características clínicas, historia natural y predictores pronósticos

Author

Barge-Caballero, Gonzalo, primary, Vázquez-García, Raquel, additional, Barge-Caballero, Eduardo, additional, Couto-Mallón, David, additional, Paniagua-Martín, María J., additional, Barriales-Villa, Roberto, additional, Piñón-Esteban, Pablo, additional, Bouzas-Mosquera, Alberto, additional, Pombo-Otero, Jorge, additional, Debén-Ariznavarreta, Guillermo, additional, Vázquez-Rodríguez, José M., additional, and Crespo-Leiro, María G., additional

Published
2021
Full Text
View/download PDF

49. Balloon-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprostheses: clinical and echocardiographic long-term outcomes

Author

Mosquera, Victor X, primary, Bouzas-Mosquera, Alberto, additional, Vilela-González, Yago, additional, Velasco, Carlos, additional, Salgado-Fernández, Jorge, additional, Calviño-Santos, Ramón, additional, Vázquez-González, Nicolás, additional, Vázquez-Rodríguez, José M, additional, and Herrera-Noreña, José M, additional

Published
2021
Full Text
View/download PDF

50. Exercise testing in COVID‐19 era: Clinical profile, results and feasibility wearing a facemask

Author

Barbeito‐Caamaño, Cayetana, primary, Bouzas‐Mosquera, Alberto, additional, Peteiro, Jesús, additional, López‐Vázquez, Domingo, additional, Quintas‐Guzmán, Martín, additional, Varela‐Cancelo, Ariana, additional, Martínez‐Ruiz, Dolores, additional, Yañez‐Wonenburger, Juan Carlos, additional, Piñeiro‐Portela, Miriam, additional, and Vázquez‐Rodríguez, José Manuel, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results